Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

1.3K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.3K
Teratogenicity01:07

Teratogenicity

2.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

465
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
465

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying Chemicals of Health Concern in Hair Extensions Using Suspect Screening and Nontargeted Analysis.

Environment & health (Washington, D.C.)·2026
Same author

Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer.

NAR cancer·2026
Same authorSame journal

Lactation Interrupted: PFAS Impact on Capacity to Breastfeed Ignored.

Current environmental health reports·2026
Same author

Effects of exposure to ethinyl estradiol during pregnancy and lactation on the postinvolution mammary gland.

Journal of the Endocrine Society·2026
Same author

Association between depression and risk of colorectal cancer and polyps: A prospective cohort study from Nurses' Health Study II.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Current Issues Related to Combustion Byproducts & Human Health: A Summary of the 18th International PIC Congress.

Environment & health (Washington, D.C.)·2026
Same journal

Assessing the Evidence for Differential Health Effects of Wildfire Smoke Across Fires and Populations: A Critical Review of Recent Studies.

Current environmental health reports·2026
Same journal

Chemicals of Concern in Chemical Hair Straightening Products: A Scoping Review.

Current environmental health reports·2026
Same journal

Endocrine Disruption and Male Fertility.

Current environmental health reports·2026
Same journal

Encoding Justice with Data: Environmental Justice Screening Tools and the Limits of Quantification.

Current environmental health reports·2026
Same journal

Industrial Pollution and Health in Louisiana: A Systematic Review of Quantitative and Qualitative Studies.

Current environmental health reports·2026
See all related articles

Related Experiment Video

Updated: Aug 31, 2025

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

29.7K

Chemical Effects on Breast Development, Function, and Cancer Risk: Existing Knowledge and New Opportunities.

Jennifer E Kay1, Bethsaida Cardona2, Ruthann A Rudel2

  • 1Silent Spring Institute, Newton, MA, USA. kay@silentspring.org.

Current Environmental Health Reports
|August 19, 2022
PubMed
Summary
This summary is machine-generated.

Exposure to endocrine-disrupting chemicals (EDCs) is linked to adverse breast outcomes, including impaired lactation and increased cancer risk. Current methods inadequately assess these mammary gland (MG) effects, hindering prevention efforts.

Keywords:
Endocrine disrupting chemicalTest guidelineThelarcheWeaningWindow of susceptibility

More Related Videos

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

6.2K
An Ex vivo Model to Study Hormone Action in the Human Breast
12:31

An Ex vivo Model to Study Hormone Action in the Human Breast

Published on: January 8, 2015

11.6K

Related Experiment Videos

Last Updated: Aug 31, 2025

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

29.7K
Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

6.2K
An Ex vivo Model to Study Hormone Action in the Human Breast
12:31

An Ex vivo Model to Study Hormone Action in the Human Breast

Published on: January 8, 2015

11.6K

Area of Science:

  • Environmental Toxicology
  • Endocrinology
  • Reproductive Health

Background:

  • Population studies reveal concerning trends: earlier breast development, lactation difficulties, and rising breast cancer rates in young women.
  • Epidemiological and experimental studies link these adverse breast outcomes to chemical exposures, particularly endocrine-disrupting chemicals (EDCs).
  • EDCs disrupt hormonal regulation, negatively impacting mammary gland (MG) development, lactation, tissue density, and cancer susceptibility.

Purpose of the Study:

  • To outline key adverse outcomes for the mammary gland (MG) associated with chemical exposures.
  • To review human and rodent evidence linking specific exposures to these MG effects.
  • To evaluate current toxicological methods for assessing MG effects, identify limitations, and propose improvements for risk assessment.

Main Methods:

  • Review of epidemiological and experimental studies on chemical exposures and breast health.
  • Analysis of adverse outcomes in mammary glands (MGs), including lactation, development, morphology, and cancer.
  • Critique of existing toxicological testing strategies for MG endpoints.

Main Results:

  • Chemical exposures, especially EDCs, are associated with impaired lactation, altered pubertal development, increased mammographic density, and higher cancer risk.
  • Current toxicological approaches often fail to adequately detect or assess the spectrum of EDC-induced MG effects.
  • Limitations in current methods hinder the identification of harmful exposures and effective risk assessment.

Conclusions:

  • Enhanced toxicological assessment of the mammary gland (MG) is crucial for identifying harmful chemicals.
  • Strengthening MG assessment methods will improve the regulation of chemicals and the prevention of adverse health effects.
  • More rigorous evaluation of EDC impacts on breast health is needed to protect public health.